MDXHealth
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
17 dec 2007 - 09:09
Statutaire naam
MDXHealth
Titel
OncoMethylome Sciences to Profile DNA for Abbott Oncology Compounds
Bericht
Liege (Belgium) - December 17, 2007, 8:00am CET - OncoMethylome Sciences entered into a pharmacogenomic service collaboration with Abbott. Under the terms of the collaboration, OncoMethylome will assist Abbott in profiling tumors. Specifically, OncoMethylome will be testing its DNA methylation biomarkers on Abbott's biological samples.
"We are very pleased to add this collaboration to existing similar agreements and to use our high-throughput methylation platform to efficiently test our methylation biomarkers on biological samples provided by Abbott", commented Dr. Jim DiGuiseppi, Chief Technology Officer of OncoMethylome. "We are pleased that Abbott has chosen OncoMethylome and our methylation technology for this collaboration"
Financial details of the agreement were not disclosed.
Gerelateerde downloads
Datum laatste update: 05 februari 2025